Saturday 17 October 2026
Export QTRX’s income statement to Excel — free account
Quanterix Corporation
QTRX Healthcare Medical Devices
Quanterix Corporation’s revenue for fiscal 2025 (year ended December 2025) was $138.9 million, up 1.07% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS fell 35.1% and free cash flow grew 18.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
2.87
0.20
−6.51%
Follow QTRX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
1 | 3 | 3 | 3 |
| (29.28%) | (34.25%) | (34.81%) | (46.48%) | ||
| (22.37%) | (25.97%) | (27.30%) | (35.41%) | ||
ROIC |
(40.08%) | (44.21%) | (48.03%) | (66.50%) | |
Return on Tangible Assets |
(52.65%) | (66.48%) | (66.28%) | (87.51%) | |
Average Days of Receivables |
92.59 | 78.76 | 67.41 | 53.16 | |
Free Cash Flow per Share |
(1.48) | (1.87) | (1.76) | (1.73) | |
Free Cash Flow |
(68.22) | (79.85) | (82.90) | (81.68) | |
Capital Expenditures |
(3.12) | (2.61) | (1.44) | (0.76) | |
| Other line items | |||||
Cash ROIC |
(15.16%) | (19.29%) | (21.73%) | (24.70%) | |
Accounts Receivable Turnover |
4.06 | 4.47 | 5.27 | 6.69 | |
Accounts Payable Turnover |
7.76 | 7.21 | 10.31 | 9.44 | |
Inventory Turnover |
1.50 | 1.69 | 1.93 | 2.19 | |
Average Days of Payables |
58.81 | 66.98 | 39.85 | 38.16 | |
Days of Inventory on Hand |
303.98 | 270.34 | 234.58 | 204.29 | |
Tax Rate |
(0.05) | (0.05) | (0.02) | (0.02) | |
Research and Development Expense of Revenue |
27.03% | 25.86% | 22.91% | 20.83% | |
Selling, General and Administrative Expense of Revenue |
99.21% | 99.36% | 94.23% | 87.09% | |
Share Based Compensation of Revenue |
16.24% | 14.92% | 13.65% | 12.14% | |
Operating CF/Net income |
0.68 | 0.72 | 0.78 | 0.66 | |
Depreciation/Fixed assets |
0.47 | 1.00 | 1.28 | 1.59 | |
Capex/Depreciation |
(0.26) | (0.11) | (0.05) | (0.02) | |
Revenue per Share |
2.83 | 3.26 | 3.09 | 3.25 | |
Operating CF per Share |
(1.41) | (1.81) | (1.73) | (1.72) | |
Capex per Share |
(0.07) | (0.06) | (0.03) | (0.02) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 |
Columns are period end dates